Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Nsclc cell"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Cellular and Molecular Medicine
Reticulocalbin1 (RCN1) is implicated in tumorigenesis and tumour progression. However, whether RCN1‐mediated bone metastasis of non‐small cell lung cancer (NSCLC) cells was elusive. Here, we assessed the effect of osteoblast‐conditioned medium
Publikováno v:
Cell Cycle
PSMG3-AS1 is a characterized oncogenic lncRNA in breast cancer, while its role in other cancers remains unclear. This study was to investigate the role and underlying mechansim of PSMG3-AS1 in non-small cell lung cancer (NSCLC). In this study, we fou
Publikováno v:
Aging (Albany NY)
Chemo-resistance and refractoriness remain challenges for Non-small cell lung cancer (NSCLC) patients and the underlying molecular mechanisms haven't been fully explained. In this study, we investigated the influence of circUBAP2 on the NSCLC tumor c
Autor:
Muhammad Kumayl Abdulwahab, Choon Han Heh, R. Dzulkeflee, T. K. Han, R. A. Ruslan, Azhar Ariffin, Kok Hoong Leong
Publikováno v:
Russian Journal of General Chemistry. 90:2410-2418
A series of anilinoquinazoline derivatives with modification on the 2nd carbon of the aniline ring has been synthesized and characterized. The compounds have been tested for their in vitro antiproliferative activity against three NSCLC cell lines, in
Publikováno v:
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-6 (2020)
BMC Pulmonary Medicine
BMC Pulmonary Medicine
Background LncRNA SNHG10 has been reported to be an oncogenic lncRNA in liver cancer. However, its roles in non-small cell lung cancer (NSCLC) remains unknown. Methods Tumor and paired non-tumor tissues were harvested from 62 NSCLC patients. RT-qPCR
Publikováno v:
Development & Reproduction
Metformin has been widely used as an antidiabetic drug, and reported to inhibit cell proliferation in many cancers including non-small cell lung cancer (NSCLC). In NSCLC cells, metformin suppresses PI3K/AKT/mTOR signaling pathway, but effect of metfo
Publikováno v:
Journal of scientific research. 64:19-23
Autor:
Fusheng Gong, Chao Chen, Ren-Jang Lin, Zhiyong He, Ying Su, Qiang Wang, Jinghui Lin, Jinrong Liao
Publikováno v:
Translational Cancer Research
Background Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are standard treatment for advanced non-small cell lung cancer (NSCLC). However, the emergence of EGFR-TKIs resistance poses a big challenge to the treatment. Although